Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
15
BOIRF Quote, Financials, Valuation and Earnings
Last price:
$30.00
Seasonality move
:
-2.53%
Day range:
$30.00 - $30.00
52-week range:
$24.00 - $32.28
Dividend yield:
4.55%
P/E ratio:
24.71x
P/S ratio:
0.95x
P/B ratio:
1.09x
Volume:
--
Avg. volume:
7
1-year change:
5.26%
Market cap:
$520.9M
Revenue:
$527.4M
EPS (TTM):
$1.21
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Boiron SA has -- downside to fair value with a price target of -- per share.
BOIRF vs. S&P 500
-
Over the past 5 trading days, Boiron SA has underperformed the S&P 500 by -1.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Boiron SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Boiron SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Boiron SA reported revenues of --.
Earnings Growth
-
Boiron SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Boiron SA reported earnings per share of --.
Enterprise value:
404.8M
EV / Invested capital:
--
Price / LTM sales:
0.95x
EV / EBIT:
7.97x
EV / Revenue:
0.74x
PEG ratio (5yr expected):
0.76x
EV / Free cash flow:
9.27x
Price / Operating cash flow:
11.92x
Enterprise value / EBITDA:
4.80x
Gross Profit (TTM):
$404.6M
Return On Assets:
3.7%
Net Income Margin (TTM):
3.84%
Return On Equity:
5.35%
Return On Invested Capital:
5.31%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2011-12-31 | 2012-12-31 | |
| Income Statement | ||||||
| Revenue | $688.6M | $726.9M | $726.5M | -- | $216.5M | |
| Gross Profit | $541.4M | $562.1M | $565M | -- | -- | |
| Operating Income | $83.1M | $85.8M | $108.4M | -- | -- | |
| EBITDA | $110.2M | $112.2M | $143.1M | -- | -- | |
| Diluted EPS | $2.67 | $2.72 | $3.02 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $477.8M | $467.7M | $482M | $274M | -- | |
| Total Assets | $873.8M | $805M | $818.1M | $597.7M | -- | |
| Current Liabilities | $185.5M | $161.1M | $145.3M | $122.1M | -- | |
| Total Liabilities | $291.3M | $248.5M | $220.3M | $198M | -- | |
| Total Equity | $582.5M | $556.5M | $597.7M | $399.8M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-26 | 2024-12-26 | 2024-12-26 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BOIRF
Sector
Market Cap
$520.9M
$28M
Price % of 52-Week High
92.94%
51.03%
Dividend Yield
4.55%
0%
Shareholder Yield
4.82%
-1.54%
1-Year Price Total Return
5.26%
-17.48%
Beta (5-Year)
0.200
0.518
Dividend yield:
4.55%
Annualized payout:
$1.47
Payout ratio:
858.19%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$30.00
200-day SMA
Buy
Level
$27.66
Bollinger Bands (100)
Buy
Level
23.8 - 29.86
Chaikin Money Flow
Sell
Level
-35
20-day SMA
Sell
Level
$30.00
Relative Strength Index (RSI14)
Buy
Level
62.85
ADX Line
Buy
Level
32.05
Williams %R
Buy
Level
-100
50-day SMA
Buy
Level
$29.10
MACD (12, 26)
Buy
Level
0.17
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-14.8K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4587)
Buy
CA Score
(Annual)
Level (0.887)
Buy
Beneish M-Score
(Annual)
Level (-2.771)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.0072)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Boiron SA engages in the manufacturing and selling homeopathic medicines. It operates through the following geographical segments: France; Europe; North America; and Other Countries. The company offers non-proprietary, proprietary and branded homeopathic medicines. Boiron was founded by Jean Boiron and Henri Boiron on June 7, 1932 and is headquartered in Messimy, France.
Stock Forecast FAQ
In the current month, BOIRF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BOIRF average analyst price target in the past 3 months is --.
-
Where Will Boiron SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Boiron SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Boiron SA?
Analysts are divided on their view about Boiron SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Boiron SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Boiron SA's Price Target?
The price target for Boiron SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BOIRF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Boiron SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BOIRF?
You can purchase shares of Boiron SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Boiron SA shares.
-
What Is The Boiron SA Share Price Today?
Boiron SA was last trading at $30.00 per share. This represents the most recent stock quote for Boiron SA. Yesterday, Boiron SA closed at $30.00 per share.
-
How To Buy Boiron SA Stock Online?
In order to purchase Boiron SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get BOIRF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BOIRF
Sector
P/E ratio
24.71x
23.89x
PEG ratio
0.76x
-0.01x
P/B ratio
1.09x
1.82x
Price / LTM sales
0.95x
1.60x
Growth Metrics
BOIRF
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.88%
Revenue (5-year growth)
-3.3%
6.5%
Earnings forecast
--
-$0.21
Profitability
BOIRF
Sector
Profitability FY 2024
$388.1M
$3.5M
Return on invested capital
5.31%
-31.77%
Return on assets
3.7%
-27.96%
Return on equity
5.35%
-37.63%
Earnings Date
Last Earnings Date
Dec
26
Next Earnings Date
Dec
26
Estimated Next Earnings Date
Mar
27
Balance Sheet
BOIRF
Sector
Total cash
$57.2M
$26.3M
Short term investments
--
$25.7M
Total assets
$596.8M
$78M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
